Copyright
©The Author(s) 2016.
World J Respirol. Nov 28, 2016; 6(3): 69-75
Published online Nov 28, 2016. doi: 10.5320/wjr.v6.i3.69
Published online Nov 28, 2016. doi: 10.5320/wjr.v6.i3.69
Ref. | Time | No. | Infusion | Pulmonary complications | Onset | Risk factors |
Chung et al[42] | 01/1990-12/1991 | 336 patients | Iodized oil (3-40 mL) with Doxorubicin (20-60 mg) | Any pulmonary symptoms: 11 (3.27%) Pulmonary oil embolism: 6 (1.79%) Death: 1 (0.3%) | 2-5 d | Iodized oil > 20 mL |
Tajima et al[44] | 06/1997-05/1999 | 44 patients | Lipiodol (0-10 mL) with Doxorubicin derivatives (0-50 mg) | Dyspnea or hemoptysis: 2 (4.5%) | – | Via right inferior phrenic artery |
Sakamoto et al[45] | 1998 | 850 patients 2300 procedures | Iodized oil (2-15 mL) with drug mix, including Doxorubicin (10-30 mg) | Pulmonary oil embolism: 4 (0.17%) | – | Via right inferior phrenic artery |
Xia et al[59] | 01/1997-02/2004 | 1348 patients 2012 procedures | Lipiodol (5-40 mL) with Chemotherapeutic agents | Pulmonary oil embolism: 1 (0.05%) | 6 h | Lipiodol 25 mL infusion |
Wu et al[41] | 01/2005-12/2008 | 219 patients | Lipiodol (4-50 mL) with Doxorubucin (6-60 mg) | Pulmonary oil embolism: 20 (9.1%) Death: 5 (2.3%) | – | Lipiodol > 14.5 mL |
Wu et al[60] | 01/2006-12/2006 | 89 patients | Lipiodol (4-50 mL) without or with Doxorubicin (6-60 mg) | Pulmonary oil embolism: 4 (4.5%) | 1 h-4 d | Lipiodol 20-50 mL infusion |
Xu et al[40] | 01/2010-03/2012 | 478 patients 1026 procedures | Iodized oil (10-40 mL) with Epirubicin (20-60 mg) | Pulmonary oil embolism: 11 (2.3%) Death: 3 (0.6%) | 0 h-2 d | Tumor size > 10 cm Lipiodol > 20 mL |
Post-TACE pulmonary complications | Ref. |
Pulmonary oil embolism | Lin et al[43] |
Weng et al[61] | |
References from Table 1 | |
Interstitial pneumonitis | Adaddin et al[57] |
Chemical pneumonitis | Kwok et al[62] |
ALI/ARDS | Khan et al[56] |
Samejima et al[63] | |
Czauderna et al[64] | |
Hatamaru et al[47] | |
Toro et al[65] | |
Wu et al[60] | |
Nhu et al[1] | |
Lipoid pneumonia | Taupin et al[55] |
Acute eosinophilic and neutrophilic pneumonia | Alifakioti et al[58] |
Bilious pleuritis | Ichikawa et al[66] |
Pulmonary abscess | Cubiella et al[67] |
Pulmonary tumor embolism | Kwok et al[62] |
Pulmonary metastasis with HCC | Liou et al[49] |
- Citation: Nhu QM, Knowles H, Pockros PJ, Frenette CT. Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Respirol 2016; 6(3): 69-75
- URL: https://www.wjgnet.com/2218-6255/full/v6/i3/69.htm
- DOI: https://dx.doi.org/10.5320/wjr.v6.i3.69